IndiaTickerLatest filing: Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
ObservedCompany dossier
Zydus Life Science
NSE:ZYDUSLIFE · ISIN INE010B01027
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Zydus Life Science
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Mar 2026 · revenue ₹7,587 Cr · PAT ₹1,341 Cr.
Exchange XBRLLatest ownership: promoter group 75.01% and public 24.99% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
BSE · exchange filing
Observed
Source filing Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · exchange filing
Observed
Source filing Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · exchange filing
Reported financials
Full financials →31 Mar 2026
- Revenue from operations
- ₹7,587 Cr
- Profit after tax
- ₹1,341 Cr
- EPS
- ₹12.65
Observed BSE structured filing · consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 75.01%
- Public
- 24.99%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL